| CAS No. | 28529-99-9 |
| Molecular Formula | Br6IrNa |
| Molecular Weight | 694.63 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
The occurrence of Sodium hexabromoiridate(IV) is closely related to a salt form, bromine substitution in its molecular formula, which determines its behaviour during synthesis, purification, or degradation.
CATO supplies Sodium hexabromoiridate(IV) (CAS 28529-99-9), a certified reference material (molecular formula Br6IrNa, MW 694.63 g/mol) for analytical method development and quality control.
The molecular framework of Sodium hexabromoiridate(IV) (Br6IrNa) is characterized by a salt form, bromine substitution. In reversed-phase chromatography, its retention is governed primarily by the polarity and ionization state of its functional groups, which provides a practical basis for HPLC-UV/DAD or LC-MS method development. Halogen substitution (F/Cl/Br/I) produces a distinctive isotope pattern in mass spectrometry, a valuable aid for qualitative confirmation.
This reference standard is suitable for quantitative analysis on major chromatographic platforms including HPLC, GC, LC-MS/MS, and GC-MS, serving as an external calibration standard or a system suitability test reference material.
As a certified reference material (CRM), Sodium hexabromoiridate(IV) meets the metrological traceability requirements of ISO/IEC 17025 laboratories. Batch-to-batch consistency is monitored via control charts to guarantee comparable assigned values across lots.
| Molecular Formula | Br6IrNa |
| Molecular Weight | 694.63 g/mol |
| Purity | 97%+ |
| Storage | Store at room temperature |
| Solubility (reference) | Freely soluble in water |
| Stability | Stable under recommended storage conditions |
| CAS Registry Year (est.) | 1965 |
| Halogen Content | Br-containing |